These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27003516)

  • 1. Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold.
    Crowley VM; Khandelwal A; Mishra S; Stothert AR; Huard DJ; Zhao J; Muth A; Duerfeldt AS; Kizziah JL; Lieberman RL; Dickey CA; Blagg BS
    J Med Chem; 2016 Apr; 59(7):3471-88. PubMed ID: 27003516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.
    Mishra SJ; Ghosh S; Stothert AR; Dickey CA; Blagg BS
    ACS Chem Biol; 2017 Jan; 12(1):244-253. PubMed ID: 27959508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.
    Crowley VM; Huard DJE; Lieberman RL; Blagg BSJ
    Chemistry; 2017 Nov; 23(62):15775-15782. PubMed ID: 28857290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of radamide analogs as Grp94 inhibitors.
    Muth A; Crowley V; Khandelwal A; Mishra S; Zhao J; Hall J; Blagg BS
    Bioorg Med Chem; 2014 Aug; 22(15):4083-98. PubMed ID: 25027801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism.
    Suntharalingam A; Abisambra JF; O'Leary JC; Koren J; Zhang B; Joe MK; Blair LJ; Hill SE; Jinwal UK; Cockman M; Duerfeldt AS; Tomarev S; Blagg BS; Lieberman RL; Dickey CA
    J Biol Chem; 2012 Nov; 287(48):40661-9. PubMed ID: 23035116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma.
    Huard DJE; Crowley VM; Du Y; Cordova RA; Sun Z; Tomlin MO; Dickey CA; Koren J; Blair L; Fu H; Blagg BSJ; Lieberman RL
    ACS Chem Biol; 2018 Apr; 13(4):933-941. PubMed ID: 29402077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma.
    Stothert AR; Suntharalingam A; Huard DJ; Fontaine SN; Crowley VM; Mishra S; Blagg BS; Lieberman RL; Dickey CA
    Hum Mol Genet; 2014 Dec; 23(24):6470-80. PubMed ID: 25027323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.
    Hadden MK; Blagg BS
    J Org Chem; 2009 Jul; 74(13):4697-704. PubMed ID: 19492825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma.
    Stothert AR; Suntharalingam A; Tang X; Crowley VM; Mishra SJ; Webster JM; Nordhues BA; Huard DJE; Passaglia CL; Lieberman RL; Blagg BSJ; Blair LJ; Koren J; Dickey CA
    Sci Rep; 2017 Dec; 7(1):17951. PubMed ID: 29263415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Grp94 components interact transiently with the myocilin olfactomedin domain in vitro to enhance or retard its amyloid aggregation.
    Huard DJE; Jonke AP; Torres MP; Lieberman RL
    Sci Rep; 2019 Sep; 9(1):12769. PubMed ID: 31484937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward development of a proteostasis drug for myocilin-associated glaucoma.
    Huard DJ; Lieberman RL
    Future Med Chem; 2018 Jun; 10(12):1391-1393. PubMed ID: 29788763
    [No Abstract]   [Full Text] [Related]  

  • 12. GRP94/gp96 in Cancer: Biology, Structure, Immunology, and Drug Development.
    Wu BX; Hong F; Zhang Y; Ansa-Addo E; Li Z
    Adv Cancer Res; 2016; 129():165-90. PubMed ID: 26916005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Evaluation of 5'-(
    Tosh DK; Brackett CM; Jung YH; Gao ZG; Banerjee M; Blagg BSJ; Jacobson KA
    ACS Med Chem Lett; 2021 Mar; 12(3):373-379. PubMed ID: 33738064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the site 2 pocket of Grp94 with KUNG65 benzamide derivatives.
    Pugh K; Xu H; Blagg BSJ
    Bioorg Med Chem Lett; 2024 Oct; 111():129893. PubMed ID: 39043265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.
    Patel HJ; Patel PD; Ochiana SO; Yan P; Sun W; Patel MR; Shah SK; Tramentozzi E; Brooks J; Bolaender A; Shrestha L; Stephani R; Finotti P; Leifer C; Li Z; Gewirth DT; Taldone T; Chiosis G
    J Med Chem; 2015 May; 58(9):3922-43. PubMed ID: 25901531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.
    Que NLS; Crowley VM; Duerfeldt AS; Zhao J; Kent CN; Blagg BSJ; Gewirth DT
    J Med Chem; 2018 Apr; 61(7):2793-2805. PubMed ID: 29528635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design.
    Immormino RM; Metzger LE; Reardon PN; Dollins DE; Blagg BS; Gewirth DT
    J Mol Biol; 2009 May; 388(5):1033-42. PubMed ID: 19361515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90.
    Huck JD; Que NLS; Immormino RM; Shrestha L; Taldone T; Chiosis G; Gewirth DT
    J Biol Chem; 2019 Nov; 294(44):16010-16019. PubMed ID: 31501246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport.
    Ghosh S; Shinogle HE; Galeva NA; Dobrowsky RT; Blagg BS
    J Biol Chem; 2016 Apr; 291(16):8309-23. PubMed ID: 26872972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.
    Clevenger RC; Blagg BS
    Org Lett; 2004 Nov; 6(24):4459-62. PubMed ID: 15548050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.